Etienne Scherrer
About Etienne Scherrer
Etienne Scherrer serves as the Brand Lead for US Marketing at Kite Pharma, a position he has held since 2020. He has extensive experience in the pharmaceutical industry, having held various marketing and commercial roles at companies such as Bristol-Myers Squibb, Gilead Sciences, and Shire Pharmaceuticals.
Current Role at Kite Pharma
Etienne Scherrer serves as the Brand Lead for US Marketing at Kite Pharma. He has held this position since 2020 and is based in Santa Monica, California. In this role, he is responsible for overseeing marketing strategies and initiatives aimed at promoting Kite Pharma's products within the US market.
Previous Experience at Kite Pharma
Prior to his current role, Etienne Scherrer worked at Kite Pharma as the Head of Marketing and Commercial Operations for Europe from 2019 to 2020. During his tenure in London, United Kingdom, he focused on developing and implementing marketing strategies tailored to the European market.
Career at Shire Pharmaceuticals
Etienne Scherrer was employed at Shire Pharmaceuticals as the Director of New Product Marketing in Hematology from 2012 to 2014. His work in this role involved leading marketing efforts for new hematology products, contributing to the company's portfolio in this therapeutic area.
Experience at Bristol-Myers Squibb
Etienne Scherrer has extensive experience at Bristol-Myers Squibb, where he held multiple roles. He served as a Senior Product Manager in US Virology from 2005 to 2008, and as Associate Director of Global Marketing in Virology from 2003 to 2005. Additionally, he worked as a Sales Representative in US Primary Care from 2002 to 2003 and as Associate Product Manager for Virology Europe from 2000 to 2002. His roles encompassed various aspects of product management and marketing.
Tenure at Gilead Sciences
From 2014 to 2019, Etienne Scherrer worked at Gilead Sciences as the Therapeutic Area Lead for Commercial Planning in Oncology. In this position, he was responsible for strategic planning and commercial operations within the oncology therapeutic area, contributing to Gilead's initiatives in this field.